Close

Context's (CNTX) Partner Stemline Therapeutics Announces FDA Approval of ORSERDU

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. GM
3. SPY
4. SHW
5. SPOT
6. AMZN
7. AAPL
8. NVDA
9. MTTR
10. MINN


Go back to Context's (CNTX) Partner Stemline Therapeutics Announces FDA Approval of ORSERDU
(NASDAQ: CNTX) Delayed: 1.41 +0.05 (3.68%)
Previous Close $1.36    52 Week High $ 
Open $1.45    52 Week Low $ 
Day High $1.48    P/E N/A 
Day Low $1.38    EPS $ 
Volume 22,853